bromocriptine has been researched along with Endometrial Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, K; Maekawa, A; Nishikawa, A; Suzuki, T; Takahashi, M; Taya, K; Watanabe, G; Yoshida, M | 1 |
| Stanosz, S | 1 |
| Barri, PN; Dexeus, S | 1 |
3 other study(ies) available for bromocriptine and Endometrial Neoplasms
| Article | Year |
|---|---|
Long-term treatment with bromocriptine inhibits endometrial adenocarcinoma development in rats.
Topics: Adenocarcinoma; Animals; Bromocriptine; Carcinogens; Endometrial Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Histocytochemistry; Hormone Antagonists; Inhibins; Luteinizing Hormone; Methylnitronitrosoguanidine; Progesterone; Prolactin; Rats | 2009 |
An attempt at conservative treatment in selected cases of type I endometrial carcinoma (stage I a/G1) in young women.
Topics: Adult; Bromocriptine; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Estriol; Female; Humans; Metformin; Progesterone; Young Adult | 2009 |
Hyperprolactinemia: an inductor of neoplastic changes in endometrium? A report of two cases.
Topics: Adenocarcinoma; Adult; Bromocriptine; Endometrial Neoplasms; Female; Humans; Hyperprolactinemia; Hysterectomy | 1998 |